News | Cardiovascular Ultrasound | June 19, 2019

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

Studies will be presented at the American Society of Echocardiography (ASE19) 30th Annual Scientific Session

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

June 19, 2019 — DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's LVivo EF artificial intelligence (AI)-based solution that generates fully automated left ventricular ejection fraction (LVEF). EF is a main indicator in assessing the global function of the left ventricle. Presently, many readers quantify EF visually or trace endocardial borders that may not be well defined, yielding high variability among results. LVivo EF aims to substantially reduce this variability by generating objective, accurate and fast AI-based EF.

The studies were led by Martin Goldman, M.D., Solomon Bienstock, M.D., Rajeev Samtani, M.D., Steve Liao, M.D., Usman Baber, M.D., Arieh Greenbaum, M.D., Lori B. Croft, M.D., and Eric Stern, M.D., from Mount Sinai Hospital, New York.

The first study, "Validation of a Novel Artificial Intelligence Left Ventricular Ejection Fraction Quantification Software (LVivo EF by DIA) by Cardiac MRI,"1 tested the accuracy of the LVivo EF tool on 76 patients by retrospectively running it on cardiac four-chamber clips. The LVivo EF results were then compared to those obtained by magnetic resonance imaging (MRI) EF as a gold standard. The study indicated a strong correlation between cardiac MRI and LVivo EF (R2=0.89), and it suggests that LVivo EF may be used over a wide range of cardiac function, to evaluate EF in a fast and accurate manner.

"This study further validated DiA's AI-based tool, LVivo EF, against cardiac MRI EF, a recognized gold standard for the assessment of cardiac function. Based on the study's findings, LVivo EF has the potential to provide accurate and objective quantification of LVEF to support clinicians in the decision-making process, right at the patient's bedside, saving time and resources. This is specifically important in patients with low EF, where accuracy has clinical and therapeutic implications. Moreover, by providing the endocardial border overlay on the moving images, it also facilitates immediate confirmation of its accuracy by the reader," said Goldman, associate director of the CV Institute, director of the Fellowship Training Program and director of medical education at the Icahn School of Medicine at Mount Sinai Hospital.

The successful validation of LVivo EF as compared to MRI EF, led the team to publish a second study comparing LVivo EF results to physician's evaluation of EF using transthoracic echocardiography (TTE), with and without contrast agents, entitled "Fully Automated Echocardiographic Artificial Intelligence Software (LVivo EF by DiA) Could Replace Contrast Agents for Improving Accuracy of Left Ventricular Ejection Fraction Quantification." Results indicated that in non-contrast studies compared to cardiac MRI, LVivo EF was significantly better than physicians' assessments (R2=0.823 compared to R2=0.622), while for contrast studies, which are often used to improve LVEF analysis, LVivo EF on non-contrast images and physicians' quantification of contrast-enhanced images were similar (R2=0.913 and R2=0.873).

Both studies will be presented by Bienstock at the American Society of Echocardiography (ASE) 30th Annual Scientific Session, June 22-24 in Portland, Ore.

For more information: www.dia-analysis.com

Related Content

The impact of deploying artificial intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients.

Getty Images

News | Artificial Intelligence | June 15, 2021
June 15, 2021 — The impact of deploying ...
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.

Getty Images

News | Women's Health | June 15, 2021
June 15, 2021 — The prevalence of genetic mutations associated with breast cancer in Black and white women is the sam
A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.

Cardiac Magnetic Resonance Imaging in Athletes With Clinical and Subclinical Myocarditis A-D, Athlete A with subclinical possible myocarditis was asymptomatic with normal electrocardiogram (ECG), echocardiogram, and high-sensitivity troponin findings. A, T2 mapping showing elevated T2 in basal-mid inferolateral wall in short axis view. B, late gadolinium enhancement (LGE) in the basal inferolateral wall in short axis view. C, Postcontrast steady state-free precession (SSFP) images showing contrast uptake in the basal-mid inferolateral wall in short axis view. D, LGE in the inferolateral wall in 3-chamber view. E-H, Athlete B with subclinical probable myocarditis was asymptomatic with normal ECG, normal echocardiogram, and elevated high-sensitivity troponin findings. E, T2 mapping showing elevated T2 in the anteroseptal wall in short axis view. F, LGE in the anteroseptal wall in 3-chamber view. G, T2 mapping showing elevated T2 in the anteroseptal wall in 3-chamber view. F, Postcontrast SSFP image showing pericardial effusion in short axis view. I-K, Athlete C with clinical myocarditis and chest pain, dyspnea, abnormal ECG, normal echocardiogram, and normal troponin findings. I, T2 mapping showing elevated T2 in the lateral wall short axis view. J, Postcontrast SSFP images showing contrast uptake in midlateral wall in short axis view. K, LGE in the epicardial midlateral wall in short axis view. L-N, Athlete D with clinical myocarditis, chest pain, abnormal ECG, echocardiogram, and troponin findings. L, T1 mapping showing elevated native T1 in midlateral wall in short axis view. M, T2 mapping showing elevated T2 in the midlateral wall in short axis view. N, LGE in the epicardial midlateral wall in short axis view. IR indicates inferior right view; IRP, inferior, right, posterior view; PLI, posterior, left, inferior view; SL, superior left view; SLA, superior, left, anterior view. Image courtesy of JAMA Cardiol. Published online May 27, 2021. doi:10.1001/jamacardio.2021.2065

News | Cardiac Imaging | June 15, 2021
June 15, 2021 — A...
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan #CT
News | Computed Tomography (CT) | June 14, 2021
June 14, 2021 — Heart disease and cancer are the ...
Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

News | SPECT Imaging | June 14, 2021
June 14, 2021 — An advanced artificial i...
The new X-ray scanner can provide detailed information about the internal makeup of rocks, which could be useful for archaeologists studying fossils or miners making decisions about which ore to use in their extraction facilities. Image courtesy of Joel Greenberg, Duke University

The new X-ray scanner can provide detailed information about the internal makeup of rocks, which could be useful for archaeologists studying fossils or miners making decisions about which ore to use in their extraction facilities. Image courtesy of Joel Greenberg, Duke University

News | X-Ray | June 10, 2021
June 10, 2021 — Engineers at Duke University have demonstrated a prot
Richard Ernst was considered the father of nuclear magnetic resonance imaging (MRI)
News | Magnetic Resonance Imaging (MRI) | June 10, 2021
June 10, 2021 — The Washington Post has reported that Richard R.
The Town of Burlington, Mass., and Butterfly Network, Inc. are pleased to announce that Butterfly, an innovative digital health company with a mission to democratize access to medical imaging, will build its brand-new corporate headquarters at The District Campus in Burlington.
News | Ultrasound Imaging | June 08, 2021
June 8, 2021 — The Town of Burlington, Mass., and Butterfly...
The U.S. Food and Drug Administration (#FDA) approved #Aduhelm (#aducanumab) for the treatment of #Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.

Getty Images

News | PET Imaging | June 07, 2021
June 7, 2021 — The U.S.